24-May-2022 | D | Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has recommended Final Dividend of 10% (Rs. 1/- per equity share of Rs. 10/- each) for the Financial Year ended March 31, 2022, subject to the approval of the members at the ensuing Annual General Meeting (AGM). The said dividend, if declared at the ensuing Annual General Meeting (AGM), will be paid to the shareholders within 30 days of AGM of the Company.
Decided to hold 101st Annual General Meeting on September 14, 2022. | 06-Sep-2022 | |
21-May-2021 | D | Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2021, inter alia, has recommended Final Dividend of 5% (Re. 0.50 Paisa per equity share of Rs. 10/- each) for the Financial Year ended March 31, 2021, subject to the approval of the members at the ensuing Annual General Meeting (AGM). The said dividend, if declared at the ensuing Annual General Meeting (AGM), will be paid to the shareholders within
30 days of AGM. | 14-Sep-2021 | |
08-Feb-2021 | D | Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 08, 2021, inter alia, have declared an Interim Dividend of Rs. 1.00 per Equity Share (i.e. 10% ) on the face value of Rs. 10/- each for the Financial Year 2020-21. | 25-Feb-2021 | |
08-Sep-2020 | D | We wish to inform you that pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended, at its meeting held today through Video Conferencing, the Board of Directors have declared an Interim Dividend of Re. 0.50 per Equity Share (i.e. 5 % ) of the face value of Rs. 10/- each for the Financial Year 2020-21. The payment date of the Interim Dividend will be on or after Wednesday, 7th October 2020 i.e. within the prescribed time limit. | 24-Sep-2020 | |
28-May-2019 | D | Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended a 'Special Centenary Year (1919 to 2019)' Dividend of Rs. 1/- per equity share, subject to approval of the Shareholders at the ensuing Annual General Meeting (AGM), scheduled to be held in the month of September 2019. | 09-Sep-2019 | |
07-Dec-2018 | D | The Board of Directors as its meeting held on 7.12.2018 declared an Interim Dividend :-
On preference Shares Declared an Interim Dividend of Rs. 3.50 Lakhs ( Pro- Rata up to 30.09.2018) On Equity Shares Declared an Interim Dividend of Rs.0.50 per equity Shares of Rs.10/- each. The record date is fixed as 14.12.2018 for payment of Interim Dividend.
Dharamsi Morarji Chemical Company Ltd has informed BSE that the Company has fixed December 21, 2018 as the Record Date for the purpose of Payment of Interim Dividend.
(As Per BSE Announcement Dated On 08/12/2018) | 20-Dec-2018 | |
28-May-2018 | D | Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, have recommended a dividend of Rs. 0.50 per equity share (face value of Rs. 10/- each), i.e. 50 paise per equity share of Rs.10/- each for the year ended March 31, 2018. This dividend is payable upon approval by the Shareholders at the ensuing Annual General Meeting (AGM). | 14-Sep-2018 | |
30-Aug-2001 | R | One equity share of Rs.10/- each at par on rights basis for every two existing equity shares held.
(For DEMAT Securities)
[Refere BSE Notice dated 31.08.2001] | 19-Sep-2001 | 1:2 |
31-Jan-2024 | BC | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone & Consol | 09-Feb-2024 | |
01-Nov-2023 | BC | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited (Standalone & Conso | 08-Nov-2023 | |
09-Aug-2023 | BC | Please find enclosed herewith Unaudited Standalone and Consolidated Financial Results for the quarter ended 30.06.2023 and Board Meeting outcome.
Dear Sir/Madam, Pursuant to Regulation 34(1) of Se | 12-Sep-2023 | |
21-Aug-2023 | BC | Annual General Meeting | 06-Sep-2023 | |
02-Aug-2023 | BC | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve and take on record the Unaudited | 09-Aug-2023 | |
Announcement Date24-May-2022
Ex Dividend Date06-Sep-2022
Dividend(%)10
Announcement Date21-May-2021
Ex Dividend Date14-Sep-2021
Dividend(%)5
Announcement Date08-Feb-2021
Ex Dividend Date25-Feb-2021
Dividend(%)10
Announcement Date08-Sep-2020
Ex Dividend Date24-Sep-2020
Dividend(%)5
Announcement Date28-May-2019
Ex Dividend Date09-Sep-2019
Dividend(%)10
Announcement Date07-Dec-2018
Ex Dividend Date20-Dec-2018
Dividend(%)5
Announcement Date28-May-2018
Ex Dividend Date14-Sep-2018
Dividend(%)5
No Bonus has been declared by DHARAMSI
No Split has been declared by DHARAMSI
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)0
Ratio1:2
Book Closure
09-Feb-2024 | - | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone & Consol |
08-Nov-2023 | - | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited (Standalone & Conso |
12-Sep-2023 | - | Please find enclosed herewith Unaudited Standalone and Consolidated Financial Results for the quarter ended 30.06.2023 and Board Meeting outcome.
Dear Sir/Madam, Pursuant to Regulation 34(1) of Se |
06-Sep-2023 | 01 Jan'1900 | Annual General Meeting |
09-Aug-2023 | - | DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve and take on record the Unaudited |